Cleared Traditional

K101299 - ACCU-CHEK AVIVA PLUS BLOOD GLUCOSE MONITORING SYSTEM (FDA 510(k) Clearance)

Sep 2011
Decision
499d
Days
Class 2
Risk

K101299 is an FDA 510(k) clearance for the ACCU-CHEK AVIVA PLUS BLOOD GLUCOSE MONITORING SYSTEM. This device is classified as a Glucose Dehydrogenase, Glucose (Class II - Special Controls, product code LFR).

Submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on September 21, 2011, 499 days after receiving the submission on May 10, 2010.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1345.

Submission Details

510(k) Number K101299 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 10, 2010
Decision Date September 21, 2011
Days to Decision 499 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code LFR — Glucose Dehydrogenase, Glucose
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1345